Table of Content

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview
Overview
PESTEL Analysis
Porter’s Five Forces Analysis
Supply Chain Analysis
Raw Materials Sourcing
Manufacturing
Packaging and Labeling
Distribution and Logistics
Marketing, Sales, and End User

Chapter 3 Market Dynamics
Overview
Market Drivers
Increasing Prevalence of Chronic Diseases and Aging Population
Technological Advances
Patient Preference for Self-Administration
Advances in Biologics
Market Restraints
Safety Concerns
Market Opportunities
Emerging Markets
Market Challenges
Patient Compliance and Acceptance

Chapter 4 Regulatory Landscape
Overview
U.S.
EU
Japan

Chapter 5 Emerging Technologies and Developments
Emerging Technologies
3D Printing
Nanoparticle Delivery Systems
Biodegradable and Sustained Release Systems
Patent Analysis
Patents by Year
Patents by Applicant
Patents by Owner
Patents by Inventor
Patents by Jurisdiction
Clinical Trials Analysis
Clinical Trials Analysis by Type of Study
Clinical Trials Analysis by Status
Clinical Trials Analysis by Phase

Chapter 6 Market Segmentation Analysis
Segmental Breakdown
Global Market for Injectable Drug Delivery Device
Market Analysis by Product
Conventional Injectable Devices
Advanced Injectable Devices
Market Breakdown by Usage Type
Disposable Injectors
Reusable Injectors
Market Breakdown by Route of Administration
Subcutaneous
Intramuscular
Intravenous
Intradermal
Market Breakdown by Therapeutic Application
Diabetes
Oncology
Autoimmune Diseases
Other Applications
Market Breakdown by End User
Hospital and Clinics
Homecare Settings
Others
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 7 Sustainability: An ESG Perspective in the Injectable Drug Delivery Device Industry
Overview
Understanding the ESG Data
Environmental Performance
Social Performance
Governance Performance

Chapter 8 Competitive Intelligence
Overview
Strategies for Injectable Drug Delivery Device Manufacturers
Distribution Networks

Chapter 9 Appendix
Methodology
Company Profiles
AMGEN INC.
ASTRAZENECA
BD
BAXTER
B. BRAUN SE
F. HOFFMANN-LA ROCHE LTD.
GERRESHEIMER AG
LILLY
MERCK & CO. INC.
MEDTRONIC
PFIZER INC.
SANOFI
TEVA PHARMACEUTICAL INDUSTRIES LTD.
TERUMO CORP.
YPSOMED
Abbreviations
Sources



List of Figures


Summary Figure : Global Market for Injectable Drug Delivery Device, 2021–2029
Figure 1 : Supply Chain Analysis of Injectable Drug Delivery Device Industry
Figure 2 : Market Dynamics of Injectable Drug Delivery Devices
Figure 3 : Emerging Technologies in the Injectable Drug Delivery Device Market
Figure 4 : Patents Granted for Injectable Drug Delivery Device, by Year, 2021–2024*
Figure 5 : Global Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 6 : Global Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 7 : Global Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 8 : Global Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 9 : Global Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 10 : Global Market Shares of Injectable Drug Delivery Device, by Region, 2023
Figure 11 : North American Market Shares of Injectable Drug Delivery Device, by Country, 2023
Figure 12 : North American Market for Injectable Drug Delivery Device, 2021-2029
Figure 13 : North American Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 14 : North American Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 15 : North American Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 16 : North American Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 17 : North American Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 18 : European Market Shares of Injectable Drug Delivery Device, by Country, 2023
Figure 19 : European Market for Injectable Drug Delivery Device, 2021–2029
Figure 20 : European Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 21 : European Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 22 : European Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 23 : European Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 24 : European Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 25 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Country, 2023
Figure 26 : Asia-Pacific Market for Injectable Drug Delivery Device, 2021–2029
Figure 27 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 28 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 29 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 30 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 31 : Asia-Pacific Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 32 : RoW Market for Injectable Drug Delivery Device, 2021–2029
Figure 33 : RoW Market Shares of Injectable Drug Delivery Device, by Product, 2023
Figure 34 : RoW Market Shares of Injectable Drug Delivery Device, by Usage Type, 2023
Figure 35 : RoW Market Shares of Injectable Drug Delivery Device, by Route of Administration, 2023
Figure 36 : RoW Market Shares of Injectable Drug Delivery Device, by Therapeutic Application, 2023
Figure 37 : RoW Market Shares of Injectable Drug Delivery Device, by End User, 2023
Figure 38 : ESG Metrics of Injectable Drug Delivery Device Companies
Figure 39 : Amgen Inc.: Revenue Share, by Business Unit, FY 2023
Figure 40 : Amgen Inc.: Revenue Share, by Country/Region, FY 2023
Figure 41 : AstraZeneca: Revenue Share, by Business Unit, FY 2023
Figure 42 : AstraZeneca: Revenue Share, by Region/Country, FY 2023
Figure 43 : BD: Revenue Share, by Business Unit, FY 2023
Figure 44 : BD: Revenue Share, by Country/Region, FY 2023
Figure 45 : Baxter: Revenue Share, by Business Unit, FY 2023
Figure 46 : Baxter: Revenue Share, by Country/Region, FY 2023
Figure 47 : B. Braun SE: Revenue Share, by Business Unit, FY 2023
Figure 48 : B. Braun SE: Revenue Share, by Country/Region, FY 2023
Figure 49 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 50 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 51 : Gerresheimer AG: Revenue Share, by Business Unit, FY 2023
Figure 52 : Gerresheimer AG: Revenue Share, by Country/Region, FY 2023
Figure 53 : Lilly: Revenue Share, by Business Unit, FY 2023
Figure 54 : Lilly: Revenue Share, by Region, FY 2023
Figure 55 : Merck & Co. Inc.: Revenue Share, by Business Unit, FY 2023
Figure 56 : Merck & Co. Inc.: Revenue Share, by Country/Region, FY 2023
Figure 57 : Medtronic: Revenue Share, by Business Unit, FY 2023
Figure 58 : Medtronic: Revenue Share, by Country/Region, FY 2023
Figure 59 : Pfizer Inc.: Revenue Share, by Business Unit, 2023
Figure 60 : Pfizer Inc.: Revenue Share, by Country/Region, 2023
Figure 61 : Sanofi: Revenue Share, by Business Unit, FY 2023
Figure 62 : Sanofi: Revenue Share, by Country/Region, FY 2023
Figure 63 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 64 : Teva Pharmaceutical Industries Ltd.: Revenue Share, by Country/Region, 2023
Figure 65 : Terumo Corp.: Revenue Share, by Country/Region, FY 2023
Figure 66 : Terumo Corp.: Revenue Share, by Business Unit, FY 2023
Figure 67 : Ypsomed: Revenue Share, by Business Unit, FY 2023
Figure 68 : Ypsomed: Revenue Share, by Country/Region, FY 2023

List of Tables


Summary Table : Global Market for Injectable Drug Delivery Device, Through 2029
Table 1 : Diabetes by Region, 2021–2045
Table 2 : Global Incidence of All Cancers, by WHO Region, 2022–2050
Table 3 : Incidence of Cancer Cases, by Cancer Type, 2022
Table 4 : Elderly Population, by Country, 2021 and 2022
Table 5 : Regulatory Approval in the U.S. and Europe
Table 6 : Patents Granted for Injectable Drug Delivery Device, by Applicant, 2021–2024*
Table 7 : Patents Granted for Injectable Drug Delivery Device, by Owner, 2021–2024*
Table 8 : Patents Granted for Injectable Drug Delivery Device, by Inventor, 2021–2024*
Table 9 : Patents Granted for Injectable Drug Delivery Device, by Jurisdiction, 2021–2024*
Table 10 : Clinical Trials in Injectable Drug Delivery Device, by Type of Study, Through November 2024
Table 11 : Clinical Trials in Injectable Drug Delivery Device, by Status, Through October 2024
Table 12 : Clinical Trials in Injectable Drug Delivery Device, by Phase, Through October 2024
Table 13 : Global Market for Injectable Drug Delivery Device, Through 2029
Table 14 : Global Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 15 : Global Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 16 : Global Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 17 : Global Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 18 : Global Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 19 : Global Market for Injectable Drug Delivery Device, by Region, Through 2029
Table 20 : North American Market for Injectable Drug Delivery Device, by Country, Through 2029
Table 21 : North American Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 22 : North American Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 23 : North American Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 24 : North American Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 25 : North American Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 26 : European Market for Injectable Drug Delivery Device, by Country, Through 2029
Table 27 : European Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 28 : European Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 29 : European Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 30 : European Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 31 : European Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 32 : Asia-Pacific Market for Injectable Drug Delivery Device, by Country, Through 2029
Table 33 : Asia-Pacific Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 34 : Asia-Pacific Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 35 : Asia-Pacific Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 36 : Asia-Pacific Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 37 : Asia-Pacific Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 38 : RoW Market for Injectable Drug Delivery Device, by Product, Through 2029
Table 39 : RoW Market for Injectable Drug Delivery Device, by Usage Type, Through 2029
Table 40 : RoW Market for Injectable Drug Delivery Device, by Route of Administration, Through 2029
Table 41 : RoW Market for Injectable Drug Delivery Device, by Therapeutic Application, Through 2029
Table 42 : RoW Market for Injectable Drug Delivery Device, by End User, Through 2029
Table 43 : ESG Rankings for Major Injectable Drug Delivery Device Companies, 2024*
Table 44 : ESG: Environmental Overview
Table 45 : ESG: Social Performance Overview
Table 46 : ESG: Governance Overview
Table 47 : Injectable Drug Delivery Device Market: Leading Players
Table 48 : Amgen Inc.: Company Snapshot
Table 49 : Amgen Inc.: Financial Performance, FY 2022 and 2023
Table 50 : Amgen Inc.: Product Portfolio
Table 51 : Amgen Inc.: News/Key Developments, 2023
Table 52 : AstraZeneca: Company Snapshot
Table 53 : AstraZeneca: Financial Performance, FY 2022 and 2023
Table 54 : AstraZeneca: Product Portfolio
Table 55 : BD: Company Snapshot
Table 56 : BD: Financial Performance, FY 2022 and 2023
Table 57 : BD: Product Portfolio
Table 58 : BD: News/Key Developments, 2022-2024
Table 59 : Baxter: Company Snapshot
Table 60 : Baxter: Financial Performance, FY 2022 and 2023
Table 61 : Baxter: Product Portfolio
Table 62 : Baxter: News/Key Developments, 2024
Table 63 : B. Braun SE: Company Snapshot
Table 64 : B. Braun SE: Financial Performance, FY 2022 and 2023
Table 65 : B. Braun SE: Product Portfolio
Table 66 : B. Braun SE: News/Key Developments, 2022-2024
Table 67 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 68 : F. Hoffmann-La Roche Ltd.: Financials, FY 2022 and 2023
Table 69 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 70 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022-2024
Table 71 : Gerresheimer AG: Company Snapshot
Table 72 : Gerresheimer AG: Financial Performance, FY 2022 and 2023
Table 73 : Gerresheimer AG: Product Portfolio
Table 74 : Gerresheimer AG: News/Key Developments, 2022-2024
Table 75 : Lilly: Company Snapshot
Table 76 : Lilly: Financial Performance, FY 2022 and 2023
Table 77 : Lilly: Product Portfolio
Table 78 : Lilly: News/Key Developments, 2022-2024
Table 79 : Merck & Co. Inc.: Company Snapshot
Table 80 : Merck & Co. Inc.: Financial Performance, FY 2022 and 2023
Table 81 : Merck & Co. Inc.: Product Portfolio
Table 82 : Merck & Co. Inc.: News/Key Developments, 2022 and 2023
Table 83 : Medtronic: Company Snapshot
Table 84 : Medtronic: Financial Performance, FY 2022 and 2023
Table 85 : Medtronic: Product Portfolio
Table 86 : Pfizer Inc.: Company Snapshot
Table 87 : Pfizer Inc.: Financial Performance, FY 2022 and 2023
Table 88 : Pfizer Inc.: Product Portfolio
Table 89 : Pfizer Inc.: News/Key Developments, 2022
Table 90 : Sanofi: Company Snapshot
Table 91 : Sanofi: Financial Performance, FY 2022 and 2023
Table 92 : Sanofi: Product Portfolio
Table 93 : Sanofi: News/Key Developments, 2022-2024
Table 94 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 95 : Teva Pharmaceutical Industries Ltd.: Financial Performance, FY 2022 and 2023
Table 96 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 97 : Teva Pharmaceutical Industries Ltd.: News/Key Developments, 2024
Table 98 : Terumo Corp.: Company Snapshot
Table 99 : Terumo Corp.: Financial Performance, FY 2022 and 2023
Table 100 : Terumo Corp.: Product Portfolio
Table 101 : Terumo Corp.: News/Key Developments, 2022-2024
Table 102 : Ypsomed: Company Snapshot
Table 103 : Ypsomed: Financial Performance, FY 2022 and 2023
Table 104 : Ypsomed: Product Portfolio
Table 105 : Ypsomed: News/Key Developments, 2022-2024
Table 106 : Abbreviations Used in This Report
Table 107 : Report Sources